Your browser doesn't support javascript.
Emerging RNA-Dependent RNA Polymerase Mutation in a Remdesivir-Treated B-cell Immunodeficient Patient With Protracted Coronavirus Disease 2019.
Martinot, Martin; Jary, Aude; Fafi-Kremer, Samira; Leducq, Valentin; Delagreverie, Heloise; Garnier, Marc; Pacanowski, Jérôme; Mékinian, Arsène; Pirenne, France; Tiberghien, Pierre; Calvez, Vincent; Humbrecht, Catherine; Marcelin, Anne-Geneviève; Lacombe, Karine.
  • Martinot M; Infectious Diseases Department, Hôpitaux Civils de Colmar, Colmar, France.
  • Jary A; Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, AP-HP, Pitié-Salpêtrière Hospital, Department of Virology, Paris, France.
  • Fafi-Kremer S; Virology Laboratory, Strasbourg University Hospital, Strasbourg, France.
  • Leducq V; Strasbourg University, INSERM, IRM UMR-S 1109, F-67000 Strasbourg, France.
  • Delagreverie H; Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, AP-HP, Pitié-Salpêtrière Hospital, Department of Virology, Paris, France.
  • Garnier M; Virology Laboratory, Strasbourg University Hospital, Strasbourg, France.
  • Pacanowski J; Strasbourg University, INSERM, IRM UMR-S 1109, F-67000 Strasbourg, France.
  • Mékinian A; Sorbonne Université, GRC 29, APHP, DMU DREAM, Anesthesiology and Intensive Care Department, Saint-Antoine Hospital, Paris, France.
  • Pirenne F; Infectious Diseases Department, Saint-Antoine Hospital, APHP - Sorbonne Université, Paris, France.
  • Tiberghien P; Sorbonne Université, Internal Medicine Department, Inflammation-Immunopathology-Biotherapy Department (DMU i3D), Saint-Antoine Hospital, AP-HP, Paris, France.
  • Calvez V; Etablissement Français du Sang, La Plaine St-Denis - France.
  • Humbrecht C; Institut Mondor de Recherche Biomédicale, Unité 955, Equipe 2: Transfusion et Maladies du Globule Rouge, INSERM, EFS, Université Paris-Est Créteil, Créteil, France.
  • Marcelin AG; Etablissement Français du Sang, La Plaine St-Denis - France.
  • Lacombe K; UMR 1098 RIGHT Inserm Université de Franche-Comté Etablissement Français du Sang, Besançon.
Clin Infect Dis ; 73(7): e1762-e1765, 2021 10 05.
Article in English | MEDLINE | ID: covidwho-1455264
ABSTRACT
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a newly discovered virus for which remdesivir is the only antiviral available. We report the occurrence of a mutation in RdRP (D484Y) following treatment with remdesivir in a 76-year-old female with post-rituximab B-cell immunodeficiency and persistent SARS-CoV-2 viremia. A cure was achieved after supplementation with convalescent plasma.
Subject(s)
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: RNA-Dependent RNA Polymerase / COVID-19 / COVID-19 Drug Treatment Type of study: Case report Limits: Aged / Female / Humans Language: English Journal: Clin Infect Dis Journal subject: Communicable Diseases Year: 2021 Document Type: Article Affiliation country: Cid

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: RNA-Dependent RNA Polymerase / COVID-19 / COVID-19 Drug Treatment Type of study: Case report Limits: Aged / Female / Humans Language: English Journal: Clin Infect Dis Journal subject: Communicable Diseases Year: 2021 Document Type: Article Affiliation country: Cid